← FDA DRUG APPROVALS

FDA ANDA · ANDA203738

FLUDARABINE PHOSPHATE

Sponsor: ACTAVIS LLC

APPLICATION
ANDA203738
TYPE
ANDA
ORIGINAL APPROVAL
2017-02-28
LATEST ACTION
2025-07-01
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FLUDARABINE PHOSPHATEDiscontinued
FLUDARABINE PHOSPHATE 50MG/2ML (25MG/ML) · INJECTABLE · INJECTION

Approval history

2025-07-01Labeling · Supplement 3 · standardAP
2017-02-28UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →